The role of β2 microglobulin levels in monitoring chronic hepatitis B


Creative Commons License

Yegane S., Revanli M., TANELİ F.

Tohoku Journal of Experimental Medicine, cilt.203, sa.1, ss.53-57, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 203 Sayı: 1
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1620/tjem.203.53
  • Dergi Adı: Tohoku Journal of Experimental Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.53-57
  • Anahtar Kelimeler: beta(2) microglobulin, chronic active hepatitis B infection, asymptomatic HBV carriers
  • Manisa Celal Bayar Üniversitesi Adresli: Evet

Özet

β2 microglobulin is one of the domains of the histocompatibility class I human leukocyte antigen (HLA) antigen. In hepatitis infection the presentation of the viral antigen on the hepatocyte in the presence of class I HLA antigens plays a significant role in the elimination of the virus. The aim of the study was to estimate the serum β2 microglobulin levels in cases of chronic hepatitis B infection. Serum β2 microglobulin levels were assessed in 65 cases with chronic hepatitis B infection including 29 pediatric and 36 adult patients as the study group and in 30 cases as seronegative control group. β2 microglobulin level was found significantly higher in chronic active Hepatitis B virus (HBV) patients compared to the asymptomatic HBV carriers and also in the chronic active HBV patients compared to control group. We are of the opinion that β2 microglobulin concentration is an indicator for monitoring chronic active HBV infections at the asymptomatic hepatitis B virus carrier patients, thus would lead to early initiation of Interferon (IFN) treatment and to monitor the effectiveness of the therapy. © 2004 Tohoku University Medical Press.